High prevalence of gastroesophageal reflux in children after lung transplantation

Pediatric Pulmonology

Volumn 40, Issue 1, 2005, Pages 68-71

  Benden, Christian ^a   Aurora, Paul ^a   Curry, Joe ^a   Whitmore, Pauline ^a   Priestley, Lorraine ^a   Elliott, Martin J ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Bronchiolitis obliterans syndrome; GERD; Pediatric lung transplantation

Indexed keywords

ACICLOVIR; AZATHIOPRINE; BASILIXIMAB; COLISTIN; COTRIMOXAZOLE; GANCICLOVIR; ITRACONAZOLE; NYSTATIN; PREDNISOLONE; TACROLIMUS;

ACUTE GRAFT REJECTION; ADOLESCENT; ARTICLE; ASPIRATION PNEUMONIA; BRONCHIOLITIS OBLITERANS; CLINICAL ARTICLE; CYSTIC FIBROSIS; CYTOMEGALOVIRUS INFECTION; DEMOGRAPHY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GASTROESOPHAGEAL REFLUX; HEART LUNG TRANSPLANTATION; HUMAN; HUMAN TISSUE; LUNG DISEASE; LUNG TRANSPLANTATION; MALE; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; SPIROMETRY; STOMACH FUNDOPLICATION; STOMACH PH;

ADOLESCENT; CHILD; FEMALE; FUNDOPLICATION; GASTROESOPHAGEAL REFLUX; GRAFT REJECTION; HEART-LUNG TRANSPLANTATION; HUMANS; LONDON; LUNG TRANSPLANTATION; MALE; PREVALENCE;

EID: 21444445544     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/ppul.20234     Document Type: Article

References (15)

1. Boucek MM, Edwards LB, Keck BM, Trulock EP, Taylor DO, Hertz MI. Registry for the International Society for Heart and Lung Transplantation: seventh official pediatric report-2004. J Heart Lung Transplant 2004;23:933-947.
2. Sharpies LD, Tamm M, McNeil K, Higenbottam TW, Stewart S, Wallwork J. Development of bronchiolitis obliterans syndrome in recipients of heart-lung transplantation-early risk factors. Transplantation 1996;61:560-566.
3. Scott JP, Higenbottam TW, Sharples L, Clelland CA, Smyth RL, Stewart S, Wallwork J. Risk factors for obliterative bronchiolitis in heart-lung transplant recipients. Transplantation 1991;51:813-817.
4. Young LR, Hadjiliadis D, Davis RD, Palmer SM. Lung transplantation exacerbates gastroesophageal reflux disease. Chest 2003;124:1689-1693.
5. Mankad PS, de Levai MR. Heart-lung transplantation. In: Franco KL, editor. Pediatric cardiopulmonary transplantation. New York: Futura; 1997. p 167-184.
6. Kahrilas PJ, Quigley EM. Clinical esophageal pH recording: a technical review for practice guideline development. Gastroenterology 1996;110:1982-1996.
7. Roca J, Burgos F, Sunyer J, Saez M, Chinn S, Anto JM, Rodriguez-Roisin R, Quanjier PH, Nowak D, Burney P. References values for forced spirometry. Group of the European Community Respiratory Health Survey. Eur Respir J 1998;11: 1354-1362.
8. Elborn JS, Shale DJ, Britton JR. Cystic fibrosis: current survival and population estimates to the year 2000. Thorax 1991;46:881-885
9. erratum in Thorax 1992;47:139.
10. Aurora P, Lynn IM. Lung transplantation and end of life issues in cystic fibrosis. Paediatr Respir Rev 2000;1:114-120.
11. Estenne M, Maurer JR, Boehler A, Egan JJ, Frost A, Hertz M, Mallory GB, Snell GI, Yousem S. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002;21:297-310.
12. Hadjiliadis D, Duane DR, Steele MP, Messier RH, Lau CL, Eubanks SS, Palmer SM. Gastroesophageal reflux disease in lung transplant recipients. Clin Transplant 2003;17:363-368.
13. Palmer SM, Miralles AP, Howell DN, Brazer SR, Tapson VF, Davis RD. Gastroesophageal reflux as a reversible cause of allograft dysfunction after lung transplantation. Chest 2000;118: 1214-1217.
14. Davis RD Jr, Lau CL, Eubanks S, Messier RH, Hadjiliadis D, Steele MP, Palmer SM. Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation. J Thorac Cardiovasc Surg 2003;125:533-542.
15. Cantu E III, Appel JZ III, Hartwig MG, Woreta H, Green C, Messier R, Palmer SM, Davis RD Jr. Early fundoplication prevents chronic allograft dysfunction in patients with gastroesophageal reflux disease. Ann Thorac Surg 2004;78:1142-1151.